Clinicopath Conf
Dengue Fever, Case 40-1989, NEJM 321:957-965989., , 1989
Specificity of Calcium Channel Autoantibodies in Lambert-Eaton Myasthenic Syndrome
Lancet 2:640-643, Sher,E.,et al, 1989
Drugs Acting on 5-Hydroxytryptamine Receptors
Editorial, Lancet 2:717-7191989., , 1989
Bromocriptine in Parkinson's Disease:A Double-Blind Study Comparing"Low-Slow"and"High-Fast"in de Novo Patients
UK Bromocriptine Res Group, JNNP 52:77-821989., , 1989
Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989
Neurological Disease Associated with Antiphospholipid Antibodies
Ann Neurol 25:221-227, Briley,D.P.,et al, 1989
Amaurosis Fugax Associated with Antiphospholipid Antibodies
Ann Neurol 25:228-232, Digre,K.B.,et al, 1989
Clinical Significance of Cerebrospinal Fluid Tests for Neurosyphilis
Ann Neurol 25:50-55, Davis,L.E.&Schmitt,J.W., 1989
Lupus Anticoagulants, Anticardiolipin Antibodies, and Cerebral Ischemia
Stroke 20:225-229, Kushner,M.&Simonian,N., 1989
Lyme Disease:Of Ticks and Titers
J Pediatr 114:328-333, Eichenfield,A.H.&Athreya,B.H., 1989
Cancer-Associated Retinopathy (Car Syndrome) with Antibodies Reacting with Retinal, Optic-Nerve, and Cancer Cells
NEJM 321:1589-1594, 1607-16081989., Thirkill,C.E.,et al, 1989
Antineural Autoantibodies in Patients with Paraneoplastic Cerebellar Degeneration
Arch Neurol 46:1225-1229, Tsukamoto,T.,et al, 1989
Anticerebellar Antibodies in Neurologically Normal Patients with Ovarian Neoplasm
Neurol 39:1605-1609, Brashear,H.R.,et al, 1989
Varicella Zoster-Associated Neurologic Disease without Skin Lesions
Arch Neurol 46:313-315, Mayo,D.R.&Booss,J., 1989
Etiology, Prognosis, and Hemostatic Function after Cerebral Infarction in Young Adults
Stroke 20:477-482, Chancellor,A.M.,et al, 1989
Cerebrovascular Disease & Antiphospholipis Antibodies in SLE, Lupus-Like Dis, & Primary Antiphospholipid Synd
Am J Med 86:391-399, Asherson,R.A.,et al, 1989
Cardiogenic Brain Embolism and Lupus Anticoagulants
Ann Neurol 26:390-392, Young,S.M.,et al, 1989
Antiphospholipid Antibodies
Ann Neurol 26:386-389, Levine,S.R.&Welch,K.M.A., 1989
Frequency, Etiology, and Prevention of Stroke in Patients with Systemic Lupus Erythematosus
Stroke 20:583-591, Futrell,N.&Millikan,C., 1989
Acute Fatal HIV Encephalitis with Negative Serologic Antibody and Antigen:Diagnosis by Polymerase Chain Reaction
NEJM 320:1494-1495, Varma,V.A.,et al, 1989
Clinicopath Conf
HTLV-I Infection, with Adult T-Cell Lymphoma and Tropical Spastic Paraparesis, Case 36-2989, NEJM 32, :6675,1989., 1989
CNS Dysfunction in Fisher's Syndrome
Neurol 39:998-999, Pessin,M.S.,et al, 1989
Lyme Disease
NEJM 321:586-596, Steere,A.C., 1989
Diagnosis of Lyme Disease
Editorial, Lancet 2:198-1991989., , 1989
Neoplastic Meningitis in Malignant Melanoma:Diagnosis with Monoclonal Antibodies
JNNP 52:881-886, Moseley,R.P.,et al, 1989
Pergolide and Selegiline for Parkinson's Disease
The Medical Letter, 31:81-841989., , 1989
Agonist Substitution in Advanced Parkinson's Disease
Neurol 39:1121-1122, Goetz,C.G.,et al, 1989
Physiology & Pharmacology of Dopamine D2-Receptors:Their Implications in Dopamine-Substitute Therapy for Park
Neurol 39:1106-1108, Mercuri,N.B.,et al, 1989
Postmortem Analysis of Adrenal-Medulla-to-Caudate Autograft in a Patient with Parkinson's Disease
Ann Neurol 25:607-614, Hurtig,H.,et al, 1989
The Efficacy of (+) -4-Propyl-9-Hydroxynaphthoxazine as Adjunctive Therapy in Parkinson's Disease
JNNP 52:732-735, Weiner,W.J.,et al, 1989
Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989
MR Imaging of Neurocysticercosis
AJR 153:857-866, Teitelbaum,G.P.,et al, 1989
Oculogyric Crisis after Metoclopramide Therapy
Optometry and Vision Science 66:179-180, Edward,M.,et al, 1989
Human Leptospirosis-A Review of 50 Cases
Infection 17:10-14, Lecour,H.,et al, 1989
Antiphospholipid Antibodies:A Risk Facor for Occlusive Ocular Vascular Disease in Systemic Lupus Erythematosus and the 'Primary' Antiphospholipid Syndrome
Ann Rheumatic Dis 48:358-361, Asherson,R.A.,et al, 1989
Paraneoplastic Syndromes Involving the Eyes
In Walsh & Hoyt's Clin Neuro-ophthal, 4th ed, Williams & Wilkins, Vol 3, p 1735-1746, Miller,N.R., 1988
Dopamine Agonists, In Parkinson's Disease and Movement Disorders
Urban & Schwarzenberg, Balt, p. 104., Jankovic,J.&Tolosa,E., 1988
Serum Antibodies to GM1 Ganglioside in Amytrophic Lateral Sclerosis
Neurol 38:1457-1461, Pestronk,A.,et al, 1988
Possible Benefit of GR43175, A Novel 5-HT1-Like Receptor Agonist for the Acute Treatment of Severe Migraine
Lancet 1:1309-1311, Doenicke,A.,et al, 1988
Treatment of Patients with Neuropathy and Anti-MAG IgM M-Proteins
Ann Neurol 24:93-97, Nobile-Orazio,E.,et al, 1988
Immunotherapy of Multiple Sclerosis
Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988
Subcutaneous Apomorphine in Parkinsonian On-Off Oscillations
Lancet 1:403-406, Stibe,C.M.H.,et al, 1988
Nosocomial Aseptic Meningitis Associated with Administration of OKT3
JAMA 259:2002-2005, Martin,M.A.,et al, 1988
Pharmacotherapy for Aphasia
Neurol 38:877-879, Albert,M.L.,et al, 1988
Clinicopath Conf
Antiphospholipid-Antibody Syndrome, ANA-Negative Systemic Lupus Erythematosus, Case Study 37-1988, N, JM :699-712,1988., 1988
A Double-Blind Randomized Crossover Trial of Bromocriptine & Placebo in Restless Legs Syndrome
Ann Neurol 24:455-458, Walters,A.S.,et al, 1988
Memory Dysfunction in Myasthenia Gravis:Evidence for Central Cholinergic Effects
Neurol 38:1173-1177, Tucker,D.M.,et al, 1988
International Symposium on Early Dopamine Agonist Therapy of Parkinson's Disease
Arch Neurol 45:204-208, Kurlan,R., 1988
Autoantibody Activity in Lambert-Eaton Myasthenic Syndrome
Editorial, Lancet 1:9201988., , 1988
An Antineuronal Autoantibody in Paraneoplastic Opsoclonus
Ann Neurol 23:528-531, Budde-Steffen,C.,et al, 1988